Provided by Tiger Fintech (Singapore) Pte. Ltd.

ACADIA Pharmaceuticals

22.71
-0.2400-1.05%
Post-market: 22.710.00000.00%17:45 EDT
Volume:6.66M
Turnover:151.59M
Market Cap:3.80B
PE:16.59
High:23.24
Open:23.07
Low:22.54
Close:22.95
Loading ...

BRIEF-Acadia Pharmaceuticals reports inducement grants under Nasdaq listing rule

Reuters
·
18 Jun

ACADIA Pharmaceuticals Announces New Inducement Awards for Employees Under 2024 Plan

Reuters
·
18 Jun

Cantor Fitzgerald Sticks to Their Buy Rating for ACADIA Pharmaceuticals (ACAD)

TIPRANKS
·
13 Jun

Acadia court ruling supports Nuplazid exclusivity into 2030, says Mizuho

TIPRANKS
·
11 Jun

ACADIA Pharmaceuticals (ACAD) Receives a Buy from Canaccord Genuity

TIPRANKS
·
10 Jun

US appeals court confirms patent validity of Acadia's Parkinson's drug

Reuters
·
10 Jun

ACADIA Pharmaceuticals Secures Court Victory Affirming Patent Protection for NUPLAZID Until 2038

Reuters
·
10 Jun

ACADIA Pharmaceuticals Inc - Nuplazid Patent Protection Extended to 2030

THOMSON REUTERS
·
10 Jun

U.S. Court of Appeals for the Federal Circuit Affirms Prior Delaware District Court Rulings in Favor of ACADIA in Nuplazid® (Pimavanserin) Composition of Matter Patent

THOMSON REUTERS
·
10 Jun

ACADIA Pharmaceuticals Inc : JP Morgan Raises Target Price to $30 From $26

THOMSON REUTERS
·
06 Jun

Director Laura Brege Reports Disposal of Common Shares of ACADIA Pharmaceuticals Inc

Reuters
·
06 Jun

ACADIA Pharmaceuticals Is Maintained at Neutral by B of A Securities

Dow Jones
·
06 Jun

Acadia Pharmaceuticals Inc. to Host R&D Day in New York City to Discuss Neurological and Rare Diseases Pipeline

Reuters
·
05 Jun

ACADIA Pharmaceuticals (ACAD) Gets a Hold from Bank of America Securities

TIPRANKS
·
05 Jun

ACADIA Pharmaceuticals Inc. Concluded Annual Stockholders Meeting

Reuters
·
30 May

ACADIA Pharmaceuticals Appoints Allyson McMillan-Youngblood as Senior VP, Rare Disease Franchise

Reuters
·
28 May

ACADIA Pharmaceuticals Appoints Allyson McMillan-Youngblood as Senior Vice President, Rare Disease Franchise

THOMSON REUTERS
·
28 May

ACADIA Pharmaceuticals Raised to Buy From Hold by Deutsche Bank

Dow Jones
·
21 May

Deutsche Bank Upgrades ACADIA Pharmaceuticals to Buy From Hold, Price Target is $20

MT Newswires Live
·
21 May

ACADIA Pharmaceuticals Inc. : Deutsche Bank Raises to Buy From Hold

THOMSON REUTERS
·
21 May